Clinical Trial Update: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

View source ↗

Summary

This completed clinical trial evaluated body mass index and metabolic changes after switching from olanzapine, risperidone, or quetiapine to aripiprazole in ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mood Disorders
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Abilify (aripiprazole)
• Risperdal (risperidone)
• SEROQUEL (QUETIAPINE)
• Zyprexa (olanzapine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED